title: Antiviral activity of a small-molecule inhibitor of filovirus infection.
abstract: There exists an urgent need to develop licensed drugs and vaccines for the treatment or prevention of filovirus infections. FGI-103 is a low-molecular-weight compound that was discovered through an in vitro screening assay utilizing a variant of Zaire ebolavirus (ZEBOV) that expresses green fluorescent protein. In vitro analyses demonstrated that FGI-103 also exhibits antiviral activity against wild-type ZEBOV and Sudan ebolavirus, as well as Marburgvirus (MARV) strains Ci67 and Ravn. In vivo administration of FGI-103 as a single intraperitoneal dose of 10 mg/kg delivered 24 h after infection is sufficient to completely protect mice against a lethal challenge with a mouse-adapted strain of either ZEBOV or MARV-Ravn. In a murine model of ZEBOV infection, delivery of FGI-103 reduces viremia and the viral burden in kidney, liver, and spleen tissues and is associated with subdued and delayed proinflammatory cytokine responses and tissue pathology. Taken together, these results identify a promising antiviral therapeutic candidate for the treatment of filovirus infections.
authors.affiliation: US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA.
authors.forename: Travis K
authors.initials: TK
authors.lastname: Warren
authors.forename: Kelly L
authors.initials: KL
authors.lastname: Warfield
authors.forename: Jay
authors.initials: J
authors.lastname: Wells
authors.forename: Sven
authors.initials: S
authors.lastname: Enterlein
authors.forename: Mark
authors.initials: M
authors.lastname: Smith
authors.forename: Gordon
authors.initials: G
authors.lastname: Ruthel
authors.forename: Abdul S
authors.initials: AS
authors.lastname: Yunus
authors.forename: Michael S
authors.initials: MS
authors.lastname: Kinch
authors.forename: Michael
authors.initials: M
authors.lastname: Goldblatt
authors.forename: M Javad
authors.initials: MJ
authors.lastname: Aman
authors.forename: Sina
authors.initials: S
authors.lastname: Bavari
mesh_terms: D000578:Amidines / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D001572:Benzofurans / Q000737:chemistry / Q000494:pharmacology*; D002522:Chlorocebus aethiops; D016207:Cytokines / Q000378:metabolism; D029043:Ebolavirus / Q000187:drug effects / Q000235:genetics; D005260:Female; D016563:Filoviridae / Q000187:drug effects* / Q000235:genetics; D018702:Filoviridae Infections / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D049452:Green Fluorescent Proteins / Q000235:genetics; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D056945:Hep G2 Cells; D006801:Humans; D007668:Kidney / Q000166:cytology; D008099:Liver / Q000473:pathology / Q000821:virology; D008297:Male; D008379:Marburg Virus Disease / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D029024:Marburgvirus / Q000187:drug effects / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D008970:Molecular Weight; D054852:Small Molecule Libraries; D014709:Vero Cells
chemical_list: D000578:Amidines; D000998:Antiviral Agents; D001572:Benzofurans; D016207:Cytokines; C550936:FGI 103; D054852:Small Molecule Libraries; D049452:Green Fluorescent Proteins